Background/Aims: To explore the effect of sulforaphane (SFN) treatment in rats through the induction of Stress Urinary Incontinence (SUI) via the Nrf2-ARE pathway. Methods: A total of 18 female rats (Sprague-Dawley) were assigned to three groups: a control group, an SUI group, and an SUI+SFN group (six rats per group). Rats in the treatment groups were induced via postpartum vaginal balloon dilation and bilateral ovariectomy. Rats in the SUI+SFN group were treated via intraperitoneal injection once per day for a total of one month. Urethral sphincter muscle histological was observed by HE and Masson staining. Peak voiding pressure and interval of micturition were measured by cystometry. Oxidative stress markers and protein expression in the Nrf2-ARE pathway were examined by immunohistochemical staining and western blotting. Results: Prolonged micturition interval and higher peak voiding pressure were observed in the SUI+SFN group. Disturbance of muscle morphology was ameliorated, muscle content was elevated, and collagen content was restrained in response to SFN treatment. The SOD, GSH-Px, and CAT activities were elevated in the SUI+SFN group compared to those in the control group. The level of cell apoptosis was decreased in SUI rats after SFN treatment; however, apoptosis was mainly located in the urethral mucosa instead of the muscle layer. SFN reduced the Bax/Bcl-2 expression ratio. Nrf2 and Nrf2 target antioxidant proteins were elevated in the SFN group. Conclusions: SFN was effective for SUI treatment via decreasing oxidative stress and activating the Nrf2-ARE pathway.
Introduction
Worldwide, more than 200 million people suffer from urinary incontinence (UI) [1] . The most common type of urinary incontinence is stress urinary incontinence (SUI), which has a disproportionally higher prevalence among women [2] . It has been reported that more than half of all women above 60 years of age suffer from SUI symptoms [3, 4] .
Medication therapy for SUI has never been satisfactory [5] . Periurethral injection of bulking agents, such as collagen, cannot provide an ideal long-term outcome and may lead to complications, such as abscess formation, voiding dysfunction, and even pulmonary embolism [6, 7] . Various sling surgeries are more efficacious and prevalent but are associated with larvaceous complications, such as urinary tract injury and infection [8] . The exact regeneration mechanism of stem cells injection therapy is unknown so safety may be a problem, which is the limitation of stem cell therapy for SUI [9] ..
Various explanations account for SUI. Vaginal delivery-caused birth trauma and menopause are widely recognized risk factors for SUI genesis in women [10] . A recent study implicated oxidative stress in the synergistic effect of birth trauma and menopauserelated SUI pathogenesis [11] . However, there are no reports of the treatment of SUI with sulforaphane (SFN), let alone studies explaining the exact mechanism. Since oxidative stress is a factor for SUI development [12] [13] [14] , antioxidants may be effective for SUI treatment. Therefore, we intend to treat SUI in a novel manner.
Nrf2 is a key regulator of cellular responses to oxidative stress or electrophilic transcription via the promotion of antioxidative gene expression through the antioxidant response element (ARE) [15] [16] [17] . SFN is a nontoxic and phytochemical compound naturally obtained from cruciferous vegetables; particularly high concentrations of SFN have been derived from broccoli and broccoli sprouts [18, 19] . The major mechanism of the antioxidative action of SFN is mediated by Nrf2, which combines with Kelch-like ECH-associated protein 1 (Keap1) within the cytoplasm under basal conditions [16] . SFN modifies the cysteines of Keap1, resulting in the translocation of Nrf2 to the nucleus, and subsequent binding to AREs leads to the expression of cytoprotective genes, such as heme oxygenase-1 (HO-1) and NAD(P)H: quinone oxidoreductase 1 (NQO1), to combat against electrophilic and oxidative stress [20, 21] .
In the present study, we explored the role of SFN in treating SUI using an SUI rat model. In addition, we also investigated whether and how the Nrf2-ARE pathway is involved in SFN treatment of SUI.
Materials and Methods

Reagents and Antibodies
Sulforaphane was obtained from Cayman Chemical (USA). Anti-Nrf2, anti-HO-1, and anti-NQO1 antibodies were acquired from Abcam (Cambridge, UK); anti-Bcl-2, anti-Bax, anti-PCNA, and anti-GAPDH antibodies were obtained from CST (Danvers, MA, USA); and goat-anti-mouse IgG-HRP, goat-anti-rabbit IgG-HRP, and the DAB detection Kit were obtained from DAKO. The TdT-mediated dUTP Nick-End Labeling (TUNEL) Apoptosis Assay Kit was obtained from KeyGEN BioTECH (Nanjing, China). The BCA assay kit was obtained from Thermo Scientific. The nuclear protein extraction kit was obtained from the Beyotime Institute of Biotechnology (Beijing, China). The malondialdehyde (MDA) assay kit, the total superoxide dismutase (SOD) assay kit, the glutathione peroxidase (GSH-Px) assay kit, and the catalase (CAT) assay kit were obtained from the Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
SUI Model and Cystometry Preparation
The Ethics Committee of the Shanghai Jiao Tong University School of Medicine approved all experimental instructions. Eighteen two-month-old primiparous female Sprague-Dawley rats, weighing 280 to 330 g, at gestational day 16, were obtained from the Animal Center of the Ninth People's Hospital of the Shanghai Jiao Tong University School of Medicine. All SD rats were bred at two animals per cage with free access to tap water and food under conditions of 20-26°C and 40-60% relative humidity under a 12 h light/dark cycle. We randomly divided the SD rats into three groups: a control group (n = 6), an SUI group (n = 6), and a SUI+SFN group (n = 6). The control group was subjected to control experiments. The SUI and SUI+SFN groups were subjected to the development of voiding dysfunction, using a previously published procedure [10, 22, 23] . Briefly, immediately after delivery, the rats were anesthetized via 10% chloral hydrate (3 mL/ kg, intraperitoneally) and then fixed in a supine position. An intravaginal balloon filled with 4 mL of saline was introduced using a transurethral 12 F catheter, which was left in situ for 4 h to simulate prolonged labor. One week later, the rats were again anesthetized using chloral hydrate and underwent bilateral ovariectomy via bilateral back incision. Gentamycin (1 mL/kg) was intramuscularly administered after surgery. From the first day after vaginal distention, we performed daily intraperitoneal injections of SFN (0.5 mg/kg) to rats in the SUI+SFN group. The control and SUI groups received the same volume of PBS with ethanol, since SFN was dissolved in ethanol and then diluted with PBS. The following experiments were conducted 30 days post vaginal distention: the rats in all groups were anesthetized via chloral hydrate 24 h prior to testing, and a catheter was placed in the bladder using a previously described procedure [24, 25] . A PE-50 polyethylene tube with a flared end, which served as an anchor, was inserted into the bladder dome. Subsequently, a 1-cm incision was made between the scapulae on the dorsum. The other end of the tube was pulled through the subcutaneous tunnel and out from the dorsum incision. We closed the dorsum incision using a purse string suture to fix the tube.
Cystometric Analysis
The cystometric analysis was performed as previously described by Liu et al. [26] . Continuous cystometry was performed in conscious rats in a metabolic cage without restraint. We connected the indwelling tube to a two-way valve. The valve was connected to an infusion pump and a pressure transducer. We ridded the system of any air bubbles to ensure continuous flow from the infusion pump. Saline was continuously infused into the bladder at a rate of 12 mL/h at room temperature in all groups. We measured cystometric parameters, such as peak voiding pressure and interval of micturition. All rats were subsequently euthanized and the bladder-urethra complex was removed for further testing.
Histological Examination and Immunohistochemical Staining
Urethral sphincter specimens were fixed in 4% paraformaldehyde, followed by paraffin embedding. The specimens were then processed and cut into sections with a thickness of 5 μm for routine staining via hematoxylin and eosin (H&E) and for IHC staining to observe the general morphology. Masson trichrome was performed to assess tissue fibrosis. We operated Immunohistochemical staining as previously reported. The 10 mM sodium citrate buffer (pH 6.0 ) were added to the sections, and then were put to heat for antigen retrieval. As the instructions of the manufacturer, we applied primary antibodies, secondary antibodies, and DAB detection kit. Two pathologists evaluated histological tissue in a blinded manner.
Masson's stain
All samples were simultaneously stained by the same experimenter to prevent staining variations. Briefly, urethral tissue sections were fully immersed in Bouin's solution (58°C) for 15 min, followed by rinsing. We subsequently stained the urethral tissue sections with Weigert Hematoxylin for 10 min and rinsed the sections until only the nuclei remained stained. Biebrich Scarlet-Acid Fuchsin was then applied to stain the urethral tissue sections for 3 min, followed by rinsing, and immersion of the tissue in phosphomolybdic acid for 45 min. Next, the urethral tissue sections were immersed in Aniline Blue for 3 min, followed by rinsing with distilled water for 2 min, staining in 1% acetic acid for 2 min, and rinsing twice with distilled water for 2 min. Subsequently, the urethral tissue sections were immersed in increasing ethanol concentrations for dehydration and air dried.
TUNEL Assay
To detect the number of apoptotic cell deaths in the urethral sphincter, we measured DNA fragmentation using a TUNEL apoptosis assay kit, according to the manufacturer's instructions. Briefly, urethral sphincter sections of each rat were placed in 1% Triton X-100, followed by enzymatic digestion with Proteinase K for 30 min. Then, the sections were incubated with TdT solution for 1 h, followed by reaction with Streptavidin-TRITC solution for 30 min in a dark, humidified chamber. The sections were incubated with DAPI for 10 min to stain the cell nuclei in the final step. The morphology and percentage of apoptotic cells was measured and observed via microscopy. 
Oxidative Stress Marker Determination
The concentrations of oxidative stress markers MDA, GSH-Px, total SOD, and CAT in the urethral sphincter tissue were measured in accordance with the manufacturer's instructions. The MDA concentration was detected at 532 nm since MDA can react with thiobarbituric acid (TBA) to reach maximum absorbance. The activity of SOD was measured at 550 nm based on its ability to react with xanthine and xanthine oxidase. Intracellular GSH was monitored at 412 nm, via enzyme-catalyzed reaction product (reduced glutathione). CAT activity was detected at 405 nm due to the reaction of hydrogen peroxide with ammonium molybdate.
Protein Extraction and Western Blotting
Briefly, we extracted protein from frozen urethral sphincter tissue via trypan-blue in RIPA buffer containing protease inhibitors. Urethral sphincter lysates were centrifuged at 10000 g/min for 10 min at 4°C; subsequently, the supernatant was removed and used as the total protein extract. We extracted the nuclear protein with a nuclear protein extraction kit according to the manufacturer's instructions. Briefly, the urethral sphincter was cut into pieces and homogenized using a cytoplasm protein extraction reagent containing protease inhibitors. The lysates were centrifuged for 5 min at 10000 g/min at 4°C. The sediment was collected and mixed with nucleoprotein extraction reagent on ice for 30 min, the lysates were centrifuged for 10 min at 10000 g/min at 4°C, and the supernatant was gathered and used as a nuclear protein extract. BCA protein assay was used to measure protein concentrations. The samples were run on 10% SDS-polyacrylamide gels (20 µg/lane), and electroblotting (200 mA) was used to transfer proteins to PVDF membranes. PVDF membranes were incubated in 5% BSA at room temperature for 2 h and washed three times in TBST via 5-min washes, followed by incubation with anti-Nrf2 (1 : 1000), HO-1 (1 : 1000), NQO1 (1 : 1000), bcl-2 (1 : 2000), Bax (1 : 2000), and GAPDH (1 : 2000) antibodies overnight at 4°C.
GAPDH was regarded as the internal normalizer. Subsequently, the membranes were washed three times in TBST for 10 min each, followed by incubation for 2 h with a goat anti-rabbit horseradish peroxidaseconjugated antibody (1 : 2000) and visualized via chemiluminescence.
Statistical Analysis
All data were displayed as the means ± SD. SPSS 16.0 was used for data processing. Differences between groups were investigated using one-way ANOVA, and a P < 0.05 was considered statistically significant.
Results
Effect of SFN on Body Weight
The body weights of control group rats were significantly higher than the weights of the rats in both SUI and SUI+SFN groups ( Table 1 ). The rats in the SUI+SFN group gained more weight than those in the SUI group. No other side effects were observed.
Improvement of Cystometric Outcomes in SUI Rats
The parameters of cystometry were recorded according to the urodynamic curve (Fig. 1) . The bladder pressure was notably decreased in rats of the SUI group relative to those of the control group. However, the peak voiding pressure in SUI rats treated via SFN was higher than the pressure in the SUI group rats at the 4-week time point. Moreover, we observed a shorter micturition interval in SUI rats than in control rats. The interval of Table 1) .
Effect of SFN on SUI Induced
Histological Changes in the Urethral Sphincter HE staining revealed notably histological changes with structural damage of the urethral sphincter muscle, muscle bundle split, and thinner muscle layer in rats of the SUI group. In the other two groups, SFN exerted a protective function on the urethral sphincter. Rats in the SUI+SFN group had a urethral sphincter muscle histological image similar to those in the control group. Rats treated with SFN had a thicker muscle layer and comparatively normal histological images, as revealed via HE staining.
Masson staining showed that after SFN treatment, the proportion of muscle areas in the urethra was significantly increased in the SUI+SFN group compared to that in the SUI group. Furthermore, the collagen content in the SUI group was higher than that in the SUI+SFN group (Fig. 2) .
Effect of SFN on Attenuating Oxidative Stress in SUI Rats
The level of oxidative stress was evaluated by measuring the levels of MDA, total SOD, GSH-Px, and CAT. The content of MDA in the urethral sphincter was notably increased in SUI rats compared to that in control rats (3.31 ± 0.74 versus 1.50 ± 0.34). The MDA level in the serum of rats of the SUI group was also significantly increased. The level of urethral MDA had decreased in SUI+SFN rats based (2.19 ± 0.37) Compared to the control group, the activities of total SOD and GSH-Px were remarkably elevated in SUI rats (93.48 ± 11.40 versus 113.90 ± 9.19 and 149.71 ± 13.09 versus 189.68 ± 18.80, respectively). Compared to the SUI group, the activities of SOD, GSH-Px, and CAT were significantly increased in the The number of apoptotic cells in the urethral sphincter of SUI rats was markedly elevated compared to that in control rats; however, the number of apoptotic cells in the urethral sphincter of SUI rats treated with SFN had notably decreased(3.67±0.29% versus 12.97±1.50% and 6.73±1.00%, respectively). Western blotting showed that the Bax/Bcl-2 expression ratio was significantly elevated in the urethral sphincter of SUI rats, consistent with the results of TUNEL staining. However, this ratio was decreased in SUI+SFN rats (Fig. 4) .
Effect of SFN on Urethral Sphincter via Activation of the Nrf2-ARE Pathway
The Nrf2 transcription factor is a crucial mediator involved in regulating cellular antioxidative reactions [27] . We investigated the effect of SFN on the expression of Nrf2, which might be activated via SFN and its downstream target proteins. The expression level of Nrf2 was notably higher in the muscular layers of the urethral sphincters of the rats in the SUI+SFN group compared to those of the rats in the SUI group, as demonstrated via the immunohistochemical imaging. Nrf2 was mainly expressed in the Onuf's nucleus in the external sphincter. We further measured Nrf2 expression in the cell and nucleus via western blotting. The results demonstrated that the total expression of Nrf2 was significantly higher in the urethral sphincter of the SUI+SFN group compared to that in the SUI group, and total Nrf2 was significantly increased in the urethral sphincter of the rats in the SUI group compared to that in the rats in the control group. The levels of HO-1 and NOQ1 (which is the downstream target proteins of Nrf2) were evaluated to measure the antioxidative function of Nrf2. Consistent with the Nrf2 expression in the nucleus, the level of HO-1 was remarkably higher in the SUI+SFN group compared to that in the SUI group. Moreover, the level of NQO1 in the urethral sphincter of the rats in the SUI+SFN group was noticeably higher than that in the rats in the SUI group, and the levels of NQO1 in the urethral sphincters of the rats in the SUI group were significantly elevated compared to that in the rats the control group (Fig. 5) .
Discussion
While various studies have demonstrated the promising potential of SFN for the treatment of numerous diseases [28, 29] , the present study may be the first to explore the feasibility of SFN for SUI treatment.
The SUI model was used in numerous studies at increasing success rates for creating abnormal voiding conditions [10, 22, 23, [30] [31] [32] . This model simulated and contained the effect of delivery, birth trauma, and menopause, three factors assumed to play a central role in the pathogenesis of lower urinary tract symptomatology [23] . Prolonged elevated pressure and intravaginal distention may cause ischemia damage to the urethra sphincter. Ischemia in turn induces oxidative stress reactions, resulting in urethral relaxation and an estrogen deficiency that increases oxidative expression and decreases urethral trophicity [11] . The use of antioxidants, such as SFN, may ameliorate oxidative stress reaction-induced SUI. Herrera-Imbroda et al. [33] suggested that human SUI is a multifactorial and complex process, and Sievert et al. [10] reported that for simulating effects of difficult labor, delivery, and menopause this modified model would be the best candidate.
The goal of the present study was to evaluate the role of SFN in the treatment of SUI via the Nrf2-ARE pathway. Therefore, we detected whether SFN stimulates Nrf2 activity in the presence of SUI, as a central regulator for cellular responses to oxidative and electrophilic stress. To determine the amount of Nrf2 in the urethral sphincter muscle, immunohistochemical imaging and western blotting were conducted among all groups. The content of Nrf2 was significantly higher in the SUI+SFN group than in the other two groups. Total Nrf2 expressed in the SUI group was higher than that of the control group. This result demonstrated that SFN could promote the Nrf2 content during treatment in the present study (four weeks total), and the overall protection would appear to operate largely via the Nrf2 pathway. More importantly, the expression of Nrf2 in the nucleus was significantly increased in rats of the SUI+SFN group. In addition, rats of the SUI group expressed more Nrf2 in the nucleus than the control group. These results implied that SFN treatment and SUI induced damage could facilitate Nrf2 translocation into the nucleus to promote its targeted antioxidant genes. Next, we used western blotting to detected transcript levels of relative genes, HO-1, and NOQ1, which are responsible for the expression of enzymes of the antioxidant synthesis pathway in the urethral sphincter. The results showed that the levels of HO-1 and NOQ1 were higher than in the other two groups; furthermore, compared to the control group, rats of the SUI group expressed more HO-1 and NOQ1. The contents of HO-1 and NOQ1 were consistent with the Nrf2 content in the nucleus. In addition, we tested the total content of CAT, GSH-Px, and SOD and the results were identical to the expression levels of HO-1 and NOQ1. Overall, The 30-day intraperitoneal injections of SFN could sustained promote the translocation of Nrf2 into the nucleus. Rats of the SUI group receiving vaginal distention damage may trigger the self protect function by the translocation of Nrf2 into the nucleus. The Nrf2 in the nucleus region could connect with AREs to boost the cytoprotective genes, such as NQO1, HO-1, to produce SOD, GSH-Px, CAT to exert antioxidative function.
To reflect the therapeutic effect of SFN on SUI, we performed urodynamic studies in conscious rats. The method of measuring urodynamic studies was consistent with Lin et al. [34] . We evaluated 
